Meet Melanoma survivor TJ Sharpe in the first installment of his new blog series on Novartis.com.

Max leads AI innovation in pharmaceutical development at Novartis. His story reflects how cutting-edge technology is combined with human expertise for meaningful impact.

Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.

In a medical treatment facility on the Thai-Burmese border, 21 patients infected with malaria recently participated in a clinical trial.

Meet our Vice President of Strategic Data and Digital at Novartis Oncology.

Novartis immunologist describes the excitement of discovering a promising new immuno-oncology (IO) target in the treatment of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).

Ilona, a patient living with polycythemia vera, shares her experiences with this rare blood cancer

Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.

After being diagnosed with an aggressive form of leukemia, Ilana Massi defied the odds with the help of her friends and family.